# 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS

> **NCT06409117** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Konstantinos Toutouzas** · enrollment: 220 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Coronary Artery Disease

## Interventions

- **DEVICE:** Percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT06409117
- **Lead sponsor:** Konstantinos Toutouzas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409117, "3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06409117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*